We characterized the differential genes in NAFLD patients versus normal patients by using various raw letter analysis methods and validated these differential genes in an external genetic dataset, finally screening for CAMK1D, CENPV, and TRHDE, and illustrating the relevance of these biomarkers to the immune microenvironment. This evidence concerns the gene CENPV and metabolic dysfunction-associated steatotic liver disease.